Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
06:45am, Wednesday, 26'th Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference.
Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records
06:00pm, Tuesday, 25'th Nov 2025
Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price
Associated Banc Corp Has $8.35 Million Stock Position in Merck & Co., Inc. $MRK
04:34am, Tuesday, 25'th Nov 2025
Associated Banc Corp cut its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 12.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and E
FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer
11:51am, Monday, 24'th Nov 2025
Merck gains FDA nod for Keytruda and Keytruda Qlex with Padcev in MIBC, marking the first PD-1 inhibitor plus ADC regimens for this patient group.
Pharma Stock Pops on Wells Fargo Upgrade
11:15am, Monday, 24'th Nov 2025
Pharmaceutical stock Merck & Co (NYSE:MRK) is up 4% at $101.64 at last glance, after an upgrade from Wells Fargo to "overweight" from "equal weight," with a price-target hike to $125 from $90.
The shortened holiday week is here, and the futures are trading higher this morning.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data across multiple hematologic malignancies will be pre
Steven Cress' 6 Picks: 3 Dividend Income, 3 AI Growth Stocks
03:45pm, Sunday, 23'rd Nov 2025
In volatile markets, Steve Cress recommends a barbell strategy: combining high-yield dividend stocks (MRK, PINE, OMF) with top AI growth stocks (MU, CLS, COMM). Seeking Alpha's quant system outperform
Boston Research & Management Inc. Grows Position in Merck & Co., Inc. $MRK
04:16am, Sunday, 23'rd Nov 2025
Boston Research and Management Inc. grew its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 7.1% during the undefined quarter, according to its most recent 13F filing with the SEC. The institut
Merck Recommends Rejection of Tutanota's “Mini-Tender” Offer
07:30pm, Friday, 21'st Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Recommends Rejection of Tutanota's “Mini-Tender” Offer.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembro
Retirement: 2 Healthcare Giants To Buy At Discounted Prices
08:00am, Friday, 21'st Nov 2025
Merck offers strong dividend growth, a robust drug pipeline, and strategic acquisitions, positioning it well beyond Keytruda's patent expiration. MRK's 3.9% dividend yield, low payout ratio, and A+ cr
Merck & Co., Inc. $MRK Shares Sold by Archer Investment Corp
04:26am, Friday, 21'st Nov 2025
Archer Investment Corp lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 9.0% in the second quarter, according to the company in its most recent filing with the Securities and Exch
Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference 2025 Transcript
12:13pm, Thursday, 20'th Nov 2025
Merck & Co., Inc. ( MRK ) Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Chirfi Guindo - Senior
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
10:51am, Thursday, 20'th Nov 2025
Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval for its faster-to-administer SC version of Keytruda.
